Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe site’s displayed revision/version has been updated from v3.5.2 to v3.5.3, indicating a minor backend/UI release rather than a change to the study record.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedLocation entry updated from Padua, Italy 35128 to Padova, Italy 35128.SummaryDifference0.0%

- Check53 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations list, and the page revision changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedPage revision from v3.4.2 to v3.4.3; no visible changes to study details, eligibility criteria, or locations.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.